Follow-up study of hypervariable region sequences of the hepatitis C virus (HCV) genome in an infant with delayed anti-HCV antibody responses

Microbiology and Immunology

Volumn 42, Issue 1, 1998, Pages 75-79

  Katayama, Yuko ^a   Tajiri, Hitoshi ^b   Tada, Kanae ^b   Okada, Shintaro ^b   Tong, Wen Yan ^a   Ishido, Satoshi ^a   Hotta, Hak ^a  

^a KOBE UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Antibody response; Follow up; Hepatitis C virus; Hypervariable region; Infant; Quasispecies

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CASE REPORT; FOLLOW UP; GENE SEQUENCE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MALE; NEWBORN INFECTION; PRESCHOOL CHILD; SEROCONVERSION; SPECIES DIFFERENCE; VIRUS GENE;

EID: 0031891309     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.1998.tb01974.x     Document Type: Article

References (16)

1. Apichartpiyakul, C., Chittivudikarn, C., Miyajima, H., Homma, M., and Hotta, H. 1994. Analysis of hepatitis C virus isolates among healthy blood donors and drug addicts in Chiang Mai, Thailand. J. Clin. Microbiol. 32: 2276-2279.
2. Chien, D.Y., Choo, Q.-L., Tabrizi, A., Kuo, C., McFarland, J., Berger, K., Lee, C., Shuster, J.R., Nguyen, T., Moyer, D.L., Tong, M., Furuta, S., Omata, M., Tegtmeier, G., Alter, H., Schiff, E., Jeffers, L., Houghton, M., and Kuo, G. 1992. Diagnosis of hepatitis C virus (HCV) infection using an immunodominant chimeric polyprotein to capture circulating antibodies: reevaluation of the role of HCV in liver disease. Proc. Natl. Acad. Sci. U.S.A. 89: 10011-10015.
3. da Silva Cardoso, M., Siemoneit, K., Nemecek, V., Epple, S., Koerner, K., and Kubanek, B. 1995. The serology of hepatitis C virus (HCV) infection: antibody crossreaction in the hypervariable region 1. Arch. Virol. 140: 1705-1713.
4. Doi, H., Apichartpiyakul, C., Ohba, K.-I., Mizokami, M., and Hotta, H. 1996. Hepatitis C virus (HCV) subtype prevalence in Chiang Mai, Thailand, and identification of novel subtypes of HCV major type 6. J. Clin. Microbiol. 34: 569-574.
5. Driesel, G., Wirth, D., Stark, K., Baumgarten, R., Sucker, U., and Schreier, E. 1994. Hepatitis C virus (HCV) genotype distribution in German isolates: studies on the sequence variability in the E2 and NS5 region. Arch. Virol. 139: 379-388.
6. Fujita, T., Ishido, S., Muramatsu, S., Itoh, M., and Hotta, H. 1996. Suppression of actinomycin D-induced apoptosis by the NS3 protein of hepatitis C virus. Biochem. Biophys. Res. Commun. 229: 825-831.
7. Houghton, M., Weiner, A., Han, J., Kuo, G., and Choo, Q.-L. 1991. Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral disease. Hepatology 14: 381-388.
8. Mellor, J., Holmes, E.C., Jarvis, L.M., Yap, P.L., Simmonds, P., and The International HCV Collaborative Study Group. 1995. Investigation of the pattern of hepatitis C virus sequence diversity in different geographical regions: implications for virus classification. J. Gen. Virol. 76: 2493-2507.
9. Murashima, S., Sata, M., Suzuki, H., Noguchi, S., and Tanikawa, K. 1996. Sequence variation of the hypervariable region in HCV carriers with normal ALT levels: a comparison with symptomatic carriers. Microbiol. Immunol. 40:941-947.
10. Okada, S.-I., Akahane, Y., Suzuki, H., Okamoto, H., and Mishiro, S. 1992. The degree of variability in the amino terminal region of the E2/NS1 protein of hepatitis C virus correlates with responsiveness to interferon therapy in viremic patients. Hepatology 16: 619-624.
11. Okamoto, H., Okada, S., Sugiyama, Y., Kurai, K., Iizuka, H., Machida, A., Miyakawa, Y., and Mayumi, M. 1991. Nucleotide sequence of the genomic RNA of hepatitis C virus isolated from a human carrier: comparison with reported isolates for conserved and divergent regions. J. Gen. Virol. 72: 2697-2704.
12. Shimizu, Y.K., Igarashi, H., Kiyohara, T., Cabezon, T., Farci, P., Purcell, R.H., and Yoshikura, H. 1996. A hyper-immune serum against a synthetic peptide corresponding to the hypervariable region 1 of hepatitis C virus can prevent viral infection in cell cultures. Virology 223: 409-412.
13. Soetjipto, Handajani, R., Lusida, M.I., Darmadi, S., Adi, P., Soemarto, Ishido, S., Katayama, Y., and Hotta, H. 1996. Differential prevalence of hepatitis C virus subtypes in healthy blood donors, patients on maintenance hemodialysis, and patients with hepatocellular carcinoma in Surabaya, Indonesia. J. Clin. Microbiol. 34: 2875-2880.
14. Taniguchi, S., Okamoto, H., Sakamoto, M., Kojima, M., Tsuda, F., Tanaka, T., Munekata, E., Muchmore, E.E., Peterson, D.A., and Mishiro, S. 1993. A structurally flexible and antigenically variable N-terminal domain of the hepatitis C virus E2/NS1 protein: implication for an escape from antibody. Virology 195: 297-301.
15. van Doorn, L.-J., Capriles, I., Maertens, G., DeLeys, R., Murray, K., Kos, T., Schellekens, H., and Quint, W. 1995. Sequence evolution of the hypervariable region in the putative envelope region E2/NS1 of hepatitis C virus is correlated with specific humoral immune responses. J. Virol. 69: 773-778.
16. Weiner, A.J., Brauer, M.J., Rosenblatt, J., Richman, K.H., Tung, J., Crawford, K., Bonino, F., Saracco, G., Choo, Q.-L., Houghton, M., and Han, J.H. 1991. Variable and hyper-variable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins. Virology 180: 842-848.